AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBK1 AND/OR IKK EPSILON

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150352108A1
SERIAL NO

14581065

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALZHEIMER'S INSTITUTE OF AMERICAPRAIRIE VILLAGE KS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bartel, Paul L Salt Lake City, US 45 125
Bursavich, Matthew Gregory Needham, US 25 259
Halter, Robert J Salt Lake City, US 11 71
Holcomb, Ryan C Salt Lake City, US 8 43
McLeod, Donald A Sandy, US 13 427
Richards, Burt Midway, US 3 30
Sebahar, Paul R Sandy, US 15 140
Shenderovich, Mark D Salt Lake City, US 6 50
Suzuki, Kazuyuki Fukushima, JP 89 930
Wettstein, Daniel A Salt Lake City, US 5 53
Yager, Kraig M Murray, US 22 114
Yungai, Ashantai J Salt Lake City, US 6 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation